Testing early seizure drug for brain protection in septic shock
Treatments studied
Part of Infections clinical trials.
This trial tests whether giving the seizure medication levetiracetam early can prevent or treat brain problems in people with septic shock. Septic shock is a life-threatening infection that can affect the brain, and this study aims to see if this drug helps protect brain function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are currently in intensive care for a severe infection that has caused shock (low blood pressure despite fluids).
- You have not been in the ICU for more than 4 days.
- You are not on long-term seizure medication and do not have uncontrolled seizures.
- You do not have a serious brain condition like dementia or a recent head injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.
This trial tests whether giving a drug called levetiracetam (which is normally used to prevent seizures) soon after a type of stroke called a brain bleed (intracerebral haemorrhage) can improve recovery. It is a randomised, double-blind trial, meaning half the participants get the drug and half get a placebo (a dummy pill), and neither you nor the doctors know which one you are taking.
This trial tests if starting a seizure medication called levetiracetam early in the ambulance, along with a specific head position, can help people having a stroke. It is for adults who show clear stroke signs within the last 2 hours and do not have other major health problems.
This study tests whether giving a seizure medication (levetiracetam) to people with brain tumors in the movement area can prevent seizures. It compares taking the medication to not taking it, starting before any seizure occurs.
This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.
This trial tests whether taking levetiracetam (a medicine used to prevent seizures) around the time of brain tumor surgery can reduce the chance of postoperative seizures. It may help people who are having surgery in the brain area where seizures are a known risk.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.